Literature DB >> 18629785

Correlation between soluble IL-2 receptor serum levels and regulatory T lymphocytes in patients with solid tumors.

F Brivio, P Lissoni, L Fumagalli, F Rovelli, R Brivio, L Vigore', G Messina, E Tisi.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2008        PMID： 18629785     DOI： 10.1177/172460080802300209

Source DB:  PubMed          Journal:  Int J Biol Markers        ISSN： 0393-6155            Impact factor:   3.248


× No keyword cloud information.
  5 in total

1.  Elevated serum soluble interleukin-2 receptor levels increase malignancy-related risk in patients on chronic hemodialysis.

Authors:  Chen XiaoHong; Shen Bo; Xiang FangFang; Guo Man; Zou JianZhou; Liu ZhongHua; Lv WenLv; Cao XueSen; Ding XiaoQiang; Zhang Boheng
Journal:  Int J Clin Oncol       Date:  2019-06-10       Impact factor: 3.402

2.  Increased serum level of soluble interleukin-2 receptor is associated with a worse response of metastatic clear cell renal cell carcinoma to interferon alpha and sequential VEGF-targeting therapy.

Authors:  Akinori Nukui; Akinori Masuda; Hideyuki Abe; Kyoko Arai; Ken-Ichiro Yoshida; Takao Kamai
Journal:  BMC Cancer       Date:  2017-05-25       Impact factor: 4.430

3.  Spontaneous regression of multiple pulmonary metastases accompanied by normalization of serum immune markers following cytoreductive nephrectomy in a patient with clear-cell renal cell carcinoma.

Authors:  Akihito Okazaki; Toshiki Kijima; Philipp Schiller; Natsumi Ishikawa; Hirotaka Fuchizawa; Kohei Takei; Issei Suzuki; Kazumasa Sakamoto; Toyonori Tsuzuki; Takao Kamai
Journal:  IJU Case Rep       Date:  2020-12-26

4.  Clinical significance of serum soluble T cell regulatory molecules in clear cell renal cell carcinoma.

Authors:  Akinori Masuda; Kyoko Arai; Daisaku Nishihara; Tomoya Mizuno; Hideo Yuki; Tsunehito Kambara; Hironori Betsunoh; Hideyuki Abe; Masahiro Yashi; Yoshitatsu Fukabori; Ken-Ichiro Yoshida; Takao Kamai
Journal:  Biomed Res Int       Date:  2014-06-25       Impact factor: 3.411

5.  Optimization of the fermentation process of Cordyceps sobolifera Se-CEPS and its anti-tumor activity in vivo.

Authors:  Shengli Yang; Hui Zhang
Journal:  J Biol Eng       Date:  2016-06-23       Impact factor: 4.355
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.